ABC efflux transporters in brain vasculature of Alzheimer's subjects
Multidrug efflux transporters of the ATP-Binding cassette (ABC) family, P-glycoprotein (Pgp), multidrug-resistance associated protein 4 (MRP4) and breast cancer resistance protein (BCRP), located on endothelial cells lining brain vasculature play important roles in limiting movement of substances in...
Saved in:
Published in | Brain research Vol. 1358; pp. 228 - 238 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Amsterdam
Elsevier B.V
28.10.2010
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Multidrug efflux transporters of the ATP-Binding cassette (ABC) family, P-glycoprotein (Pgp), multidrug-resistance associated protein 4 (MRP4) and breast cancer resistance protein (BCRP), located on endothelial cells lining brain vasculature play important roles in limiting movement of substances into and enhancing their efflux from the brain. Signals from the surrounding brain normally maintain such barrier function but these may become altered in CNS pathologies such as Alzheimer's disease (AD). Previous studies have reported decreases in the glucose transporter, Glut-1, in brain vasculature of AD patients. The present study investigates the status of the multidrug efflux transporters. Sections of frozen brain from hippocampal region obtained from male AD and age-matched non-demented cases were examined for amyloid plaques and Dkk-1 expression and subjected to dual fluorescence immunochemical staining using antibodies against Pgp, BCRP or MRP4 and von Willebrand factor. Protein expression of each transporter was assessed using confocal microscopy, quantifying peak fluorescence values of cross sectional profiles across brain microvessels. Results in brain microvessels revealed expression of Pgp protein to be significantly lower in hippocampal vessels of patients with AD compared to normal individuals whereas that of MRP4 or BCRP protein was not. By contrast, analysis of the sections at protein level via Western blotting or at transcript level by qRT-PCR did not reveal significantly lower expression for either Pgp or BCRP. Such analysis did however reveal higher than normal expression in the AD brains of MRP4, probably due to gliosis, MRP4 being present also in glial cells.
► Do conditions in Alzheimer's brains affect efflux transporters on brain microvessels? ► Immunofluorescent staining for P-glycoprotein, BCRP or MRP4 in AD and normal brains. ► Transporter levels in brain microvessels quantified by confocal microscopy. ► Pgp but not BCRP or MRP4 was significantly lower in hippocampal vessels in AD cases. ► MRP4 at non-vascular sites correlated with increased glial cell number in AD brains. |
---|---|
AbstractList | Multidrug efflux transporters of the ATP-Binding cassette (ABC) family, P-glycoprotein (Pgp), multidrug-resistance associated protein 4 (MRP4) and breast cancer resistance protein (BCRP), located on endothelial cells lining brain vasculature play important roles in limiting movement of substances into and enhancing their efflux from the brain. Signals from the surrounding brain normally maintain such barrier function but these may become altered in CNS pathologies such as Alzheimer's disease (AD). Previous studies have reported decreases in the glucose transporter, Glut-1, in brain vasculature of AD patients. The present study investigates the status of the multidrug efflux transporters. Sections of frozen brain from hippocampal region obtained from male AD and age-matched non-demented cases were examined for amyloid plaques and Dkk-1 expression and subjected to dual fluorescence immunochemical staining using antibodies against Pgp, BCRP or MRP4 and von Willebrand factor. Protein expression of each transporter was assessed using confocal microscopy, quantifying peak fluorescence values of cross sectional profiles across brain microvessels. Results in brain microvessels revealed expression of Pgp protein to be significantly lower in hippocampal vessels of patients with AD compared to normal individuals whereas that of MRP4 or BCRP protein was not. By contrast, analysis of the sections at protein level via Western blotting or at transcript level by qRT-PCR did not reveal significantly lower expression for either Pgp or BCRP. Such analysis did however reveal higher than normal expression in the AD brains of MRP4, probably due to gliosis, MRP4 being present also in glial cells.
► Do conditions in Alzheimer's brains affect efflux transporters on brain microvessels? ► Immunofluorescent staining for P-glycoprotein, BCRP or MRP4 in AD and normal brains. ► Transporter levels in brain microvessels quantified by confocal microscopy. ► Pgp but not BCRP or MRP4 was significantly lower in hippocampal vessels in AD cases. ► MRP4 at non-vascular sites correlated with increased glial cell number in AD brains. Multidrug efflux transporters of the ATP-Binding cassette (ABC) family, P-glycoprotein (Pgp), multidrug-resistance associated protein 4 (MRP4) and breast cancer resistance protein (BCRP), located on endothelial cells lining brain vasculature play important roles in limiting movement of substances into and enhancing their efflux from the brain. Signals from the surrounding brain normally maintain such barrier function but these may become altered in CNS pathologies such as Alzheimer's disease (AD). Previous studies have reported decreases in the glucose transporter, Glut-1, in brain vasculature of AD patients. The present study investigates the status of the multidrug efflux transporters. Sections of frozen brain from hippocampal region obtained from male AD and age-matched non-demented cases were examined for amyloid plaques and Dkk-1 expression and subjected to dual fluorescence immunochemical staining using antibodies against Pgp, BCRP or MRP4 and von Willebrand factor. Protein expression of each transporter was assessed using confocal microscopy, quantifying peak fluorescence values of cross sectional profiles across brain microvessels. Results in brain microvessels revealed expression of Pgp protein to be significantly lower in hippocampal vessels of patients with AD compared to normal individuals whereas that of MRP4 or BCRP protein was not. By contrast, analysis of the sections at protein level via Western blotting or at transcript level by qRT-PCR did not reveal significantly lower expression for either Pgp or BCRP. Such analysis did however reveal higher than normal expression in the AD brains of MRP4, probably due to gliosis, MRP4 being present also in glial cells. a-[ordm Do conditions in Alzheimer's brains affect efflux transporters on brain microvessels? a-[ordm Immunofluorescent staining for P-glycoprotein, BCRP or MRP4 in AD and normal brains. a-[ordm Transporter levels in brain microvessels quantified by confocal microscopy. a-[ordm Pgp but not BCRP or MRP4 was significantly lower in hippocampal vessels in AD cases. a-[ordm MRP4 at non-vascular sites correlated with increased glial cell number in AD brains. Abstract Multidrug efflux transporters of the ATP-Binding cassette (ABC) family, P-glycoprotein (Pgp), multidrug-resistance associated protein 4 (MRP4) and breast cancer resistance protein (BCRP), located on endothelial cells lining brain vasculature play important roles in limiting movement of substances into and enhancing their efflux from the brain. Signals from the surrounding brain normally maintain such barrier function but these may become altered in CNS pathologies such as Alzheimer's disease (AD). Previous studies have reported decreases in the glucose transporter, Glut-1, in brain vasculature of AD patients. The present study investigates the status of the multidrug efflux transporters. Sections of frozen brain from hippocampal region obtained from male AD and age-matched non-demented cases were examined for amyloid plaques and Dkk-1 expression and subjected to dual fluorescence immunochemical staining using antibodies against Pgp, BCRP or MRP4 and von Willebrand factor. Protein expression of each transporter was assessed using confocal microscopy, quantifying peak fluorescence values of cross sectional profiles across brain microvessels. Results in brain microvessels revealed expression of Pgp protein to be significantly lower in hippocampal vessels of patients with AD compared to normal individuals whereas that of MRP4 or BCRP protein was not. By contrast, analysis of the sections at protein level via Western blotting or at transcript level by qRT-PCR did not reveal significantly lower expression for either Pgp or BCRP. Such analysis did however reveal higher than normal expression in the AD brains of MRP4, probably due to gliosis, MRP4 being present also in glial cells. Multidrug efflux transporters of the ATP-Binding cassette (ABC) family, P-glycoprotein (Pgp), multidrug-resistance associated protein 4 (MRP4) and breast cancer resistance protein (BCRP), located on endothelial cells lining brain vasculature play important roles in limiting movement of substances into and enhancing their efflux from the brain. Signals from the surrounding brain normally maintain such barrier function but these may become altered in CNS pathologies such as Alzheimer's disease (AD). Previous studies have reported decreases in the glucose transporter, Glut-1, in brain vasculature of AD patients. The present study investigates the status of the multidrug efflux transporters. Sections of frozen brain from hippocampal region obtained from male AD and age-matched non-demented cases were examined for amyloid plaques and Dkk-1 expression and subjected to dual fluorescence immunochemical staining using antibodies against Pgp, BCRP or MRP4 and von Willebrand factor. Protein expression of each transporter was assessed using confocal microscopy, quantifying peak fluorescence values of cross sectional profiles across brain microvessels. Results in brain microvessels revealed expression of Pgp protein to be significantly lower in hippocampal vessels of patients with AD compared to normal individuals whereas that of MRP4 or BCRP protein was not. By contrast, analysis of the sections at protein level via Western blotting or at transcript level by qRT-PCR did not reveal significantly lower expression for either Pgp or BCRP. Such analysis did however reveal higher than normal expression in the AD brains of MRP4, probably due to gliosis, MRP4 being present also in glial cells. Multidrug efflux transporters of the ATP-Binding cassette (ABC) family, P-glycoprotein (Pgp), multidrug-resistance associated protein 4 (MRP4) and breast cancer resistance protein (BCRP), located on endothelial cells lining brain vasculature play important roles in limiting movement of substances into and enhancing their efflux from the brain. Signals from the surrounding brain normally maintain such barrier function but these may become altered in CNS pathologies such as Alzheimer's disease (AD). Previous studies have reported decreases in the glucose transporter, Glut-1, in brain vasculature of AD patients. The present study investigates the status of the multidrug efflux transporters. Sections of frozen brain from hippocampal region obtained from male AD and age-matched non-demented cases were examined for amyloid plaques and Dkk-1 expression and subjected to dual fluorescence immunochemical staining using antibodies against Pgp, BCRP or MRP4 and von Willebrand factor. Protein expression of each transporter was assessed using confocal microscopy, quantifying peak fluorescence values of cross sectional profiles across brain microvessels. Results in brain microvessels revealed expression of Pgp protein to be significantly lower in hippocampal vessels of patients with AD compared to normal individuals whereas that of MRP4 or BCRP protein was not. By contrast, analysis of the sections at protein level via Western blotting or at transcript level by qRT-PCR did not reveal significantly lower expression for either Pgp or BCRP. Such analysis did however reveal higher than normal expression in the AD brains of MRP4, probably due to gliosis, MRP4 being present also in glial cells.Multidrug efflux transporters of the ATP-Binding cassette (ABC) family, P-glycoprotein (Pgp), multidrug-resistance associated protein 4 (MRP4) and breast cancer resistance protein (BCRP), located on endothelial cells lining brain vasculature play important roles in limiting movement of substances into and enhancing their efflux from the brain. Signals from the surrounding brain normally maintain such barrier function but these may become altered in CNS pathologies such as Alzheimer's disease (AD). Previous studies have reported decreases in the glucose transporter, Glut-1, in brain vasculature of AD patients. The present study investigates the status of the multidrug efflux transporters. Sections of frozen brain from hippocampal region obtained from male AD and age-matched non-demented cases were examined for amyloid plaques and Dkk-1 expression and subjected to dual fluorescence immunochemical staining using antibodies against Pgp, BCRP or MRP4 and von Willebrand factor. Protein expression of each transporter was assessed using confocal microscopy, quantifying peak fluorescence values of cross sectional profiles across brain microvessels. Results in brain microvessels revealed expression of Pgp protein to be significantly lower in hippocampal vessels of patients with AD compared to normal individuals whereas that of MRP4 or BCRP protein was not. By contrast, analysis of the sections at protein level via Western blotting or at transcript level by qRT-PCR did not reveal significantly lower expression for either Pgp or BCRP. Such analysis did however reveal higher than normal expression in the AD brains of MRP4, probably due to gliosis, MRP4 being present also in glial cells. |
Author | Hladky, Stephen B. Barrand, Margery A. Bullock, Jocelyn Y. Wijesuriya, Hasini C. Faull, Richard L.M. |
Author_xml | – sequence: 1 givenname: Hasini C. surname: Wijesuriya fullname: Wijesuriya, Hasini C. organization: Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1PD, UK – sequence: 2 givenname: Jocelyn Y. surname: Bullock fullname: Bullock, Jocelyn Y. organization: Centre for Brain Research and Department of Anatomy with Radiology, University of Auckland, New Zealand – sequence: 3 givenname: Richard L.M. surname: Faull fullname: Faull, Richard L.M. organization: Centre for Brain Research and Department of Anatomy with Radiology, University of Auckland, New Zealand – sequence: 4 givenname: Stephen B. surname: Hladky fullname: Hladky, Stephen B. organization: Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1PD, UK – sequence: 5 givenname: Margery A. surname: Barrand fullname: Barrand, Margery A. email: mb10002@cam.ac.uk organization: Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1PD, UK |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23327553$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/20727860$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkl9v2yAUxdHUak27fYXKL1OfnF3AASxN07LsX6VKfdj2jDC-aHgOzsCu1n36kSbdpD40fUKg3znAOfeUHIUhICHnFOYUqHjdzZtofIiY5gzyIag58OoZmVElWSlYBUdkBgCiVHXNT8hpSl3ecl7Dc3LCQDKpBMzIh-X7VYHO9dPvYowmpM0QR4yp8KG4u6G4MclOvRmniMXgimX_5wf6NcaLVKSp6dCO6QU5dqZP-HK_npHvnz5-W30pr64_X66WV6UVXI6lU7KtnbKArpEtWmPR8rYxylphmRNSNYBC1YohrSStJVdStsCErRynzPAzcrHz3cTh14Rp1GufLPa9CThMSSsqBShZyYOkFIxJtpBPIBdCCIBaZfJ8T07NGlu9iX5t4q2-DzMDr_ZAjsz0LsdpffrPcc7kYsEzJ3acjUNKEd0_hILetqs7fd-u3rarQencbha-eSC0fjSjH0KuzveH5e92cswd3XiMOlmPwWLrY65Rt4M_bPH2gYXtffD5tz_xFlM3TDHkCdBUJ6ZBf91O4HYAKQBV9C6jRwye8oK_267t7w |
CODEN | BRREAP |
CitedBy_id | crossref_primary_10_1016_j_biopsych_2017_11_031 crossref_primary_10_3389_fnagi_2024_1368200 crossref_primary_10_1016_j_brainres_2013_04_008 crossref_primary_10_4103_1673_5374_358607 crossref_primary_10_1016_j_expneurol_2025_115189 crossref_primary_10_3390_ijms22073742 crossref_primary_10_1186_2045_8118_8_3 crossref_primary_10_3389_fphar_2018_00658 crossref_primary_10_1177_0271678X18806640 crossref_primary_10_1016_j_pharmthera_2010_12_004 crossref_primary_10_1007_s11095_014_1522_0 crossref_primary_10_1111_nan_12782 crossref_primary_10_3390_pharmaceutics16070948 crossref_primary_10_1016_j_neurobiolaging_2013_09_015 crossref_primary_10_1186_s12987_018_0113_6 crossref_primary_10_1089_neu_2015_3879 crossref_primary_10_2967_jnumed_113_130161 crossref_primary_10_1155_2017_7905486 crossref_primary_10_3389_fimmu_2021_683068 crossref_primary_10_1016_j_xcrm_2024_101609 crossref_primary_10_3390_ijms231810235 crossref_primary_10_1186_s12987_019_0158_1 crossref_primary_10_1007_s12035_020_02211_x crossref_primary_10_1016_j_addr_2011_11_010 crossref_primary_10_1016_j_nucmedbio_2015_09_001 crossref_primary_10_1080_03602532_2023_2180028 crossref_primary_10_1208_s12248_017_0077_5 crossref_primary_10_1016_j_expneurol_2020_113257 crossref_primary_10_1007_s11095_017_2263_7 crossref_primary_10_1111_febs_15148 crossref_primary_10_1016_j_xphs_2017_01_013 crossref_primary_10_3233_JAD_150350 crossref_primary_10_3390_ijms23031019 crossref_primary_10_1016_j_neuropharm_2017_08_002 crossref_primary_10_1111_jnc_15609 crossref_primary_10_1016_j_pharmr_2025_100052 crossref_primary_10_1002_1873_3468_13951 crossref_primary_10_4155_tde_11_65 crossref_primary_10_1186_1742_2094_9_150 crossref_primary_10_3390_ijms22031231 crossref_primary_10_1055_s_0041_1735541 crossref_primary_10_1186_s12987_023_00466_9 crossref_primary_10_3390_ijms21041505 crossref_primary_10_1016_j_yfrne_2020_100857 crossref_primary_10_1016_j_neuint_2014_05_004 crossref_primary_10_1186_s13550_020_00674_6 crossref_primary_10_1371_journal_pone_0250371 crossref_primary_10_3390_pharmaceutics10030102 crossref_primary_10_1016_j_biomaterials_2020_120461 crossref_primary_10_3389_fnagi_2018_00186 crossref_primary_10_1007_s00401_019_01967_4 crossref_primary_10_1016_j_arcmed_2014_11_018 crossref_primary_10_1016_j_pharmthera_2019_03_009 crossref_primary_10_1016_j_etap_2022_104003 crossref_primary_10_1016_j_arr_2024_102291 crossref_primary_10_1186_s12987_021_00245_4 crossref_primary_10_3390_brainsci10120902 crossref_primary_10_1021_cn300077c crossref_primary_10_1038_nrd_2015_21 crossref_primary_10_3233_JAD_240212 crossref_primary_10_3390_ijms22042022 crossref_primary_10_1016_j_addr_2011_12_007 crossref_primary_10_1177_0271678X221111602 crossref_primary_10_1124_pharmrev_120_000025 crossref_primary_10_1177_0271678X16660984 crossref_primary_10_1002_jcph_1709 crossref_primary_10_1155_2014_191863 crossref_primary_10_1016_j_brainres_2011_08_044 crossref_primary_10_1523_JNEUROSCI_0350_15_2016 crossref_primary_10_1007_s11095_024_03731_0 crossref_primary_10_1016_j_brainres_2015_07_005 crossref_primary_10_1016_j_pneurobio_2019_101680 crossref_primary_10_3233_JAD_170639 crossref_primary_10_1007_s11095_021_03006_y crossref_primary_10_1007_s11095_025_03826_2 crossref_primary_10_1038_cddis_2014_258 crossref_primary_10_3390_molecules22101692 crossref_primary_10_3390_ijms21218245 crossref_primary_10_1021_acs_molpharmaceut_4c00633 crossref_primary_10_1002_1873_3468_13982 crossref_primary_10_1093_brain_awac495 crossref_primary_10_18231_j_ijpp_2020_035 crossref_primary_10_1016_j_addr_2022_114282 crossref_primary_10_1186_s12987_023_00470_z crossref_primary_10_1016_j_xphs_2021_08_013 crossref_primary_10_1016_j_biomaterials_2019_119491 crossref_primary_10_1016_j_ijdevneu_2013_10_005 crossref_primary_10_1016_j_nbd_2022_105741 crossref_primary_10_1002_cpt_435 crossref_primary_10_1016_j_heliyon_2022_e09777 crossref_primary_10_3390_ijms24065438 crossref_primary_10_1016_j_neulet_2013_06_044 crossref_primary_10_3390_ijms22073356 crossref_primary_10_1021_acs_molpharmaceut_1c00549 crossref_primary_10_1146_annurev_cellbio_100617_062608 crossref_primary_10_3390_pharmaceutics14071376 crossref_primary_10_1016_j_pharmthera_2020_107554 crossref_primary_10_1002_cpt_2035 |
Cites_doi | 10.1097/00008571-200210000-00005 10.1007/s00401-009-0522-3 10.1016/j.neuron.2008.01.003 10.1007/s00702-009-0226-9 10.1038/jcbfm.2009.42 10.1016/j.neuroscience.2008.06.015 10.1146/annurev.biochem.67.1.395 10.1111/j.1750-3639.2007.00075.x 10.1073/pnas.0805165106 10.1016/j.parkreldis.2008.11.010 10.1007/s00401-006-0115-3 10.1016/j.bbapap.2009.02.014 10.1016/j.neuroscience.2004.07.051 10.1074/jbc.M100710200 10.1046/j.1471-4159.2001.00113.x 10.1016/j.pharmthera.2009.10.004 10.1038/nrn1824 10.1006/scbi.1997.0068 10.1007/s00401-008-0366-2 10.1111/j.1471-4159.2008.05537.x 10.1523/JNEUROSCI.5103-08.2009 10.1016/0197-4580(95)00021-6 10.1038/sj.tpj.6500413 10.1016/j.toxlet.2010.04.025 10.1016/j.neurobiolaging.2008.05.015 10.1083/jcb.200806024 10.1186/1750-1326-1-13 10.1073/pnas.97.7.3473 10.1016/j.brainres.2008.06.124 10.1016/j.phrs.2009.02.007 10.1523/JNEUROSCI.1381-04.2004 10.1038/cdd.2008.172 10.1038/nn1676 10.2174/156720508785132262 10.1083/jcb.114.5.1059 10.1124/mol.109.061754 10.1172/JCI25247 10.1007/BF00193951 10.1124/pr.107.07109 |
ContentType | Journal Article |
Copyright | 2010 Elsevier B.V. Elsevier B.V. 2015 INIST-CNRS Copyright © 2010 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2010 Elsevier B.V. – notice: Elsevier B.V. – notice: 2015 INIST-CNRS – notice: Copyright © 2010 Elsevier B.V. All rights reserved. |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 7TK |
DOI | 10.1016/j.brainres.2010.08.034 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Neurosciences Abstracts |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic Neurosciences Abstracts |
DatabaseTitleList | Neurosciences Abstracts MEDLINE Neurosciences Abstracts MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 1872-6240 |
EndPage | 238 |
ExternalDocumentID | 20727860 23327553 10_1016_j_brainres_2010_08_034 S0006899310018160 1_s2_0_S0006899310018160 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M -DZ -~X .1- .FO .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 23N 4.4 457 4G. 5GY 5RE 5VS 6J9 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AATTM AAXKI AAXLA AAXUO AAYWO ABCQJ ABFNM ABFRF ABIVO ABJNI ABLJU ABMAC ABTEW ABWVN ABXDB ACDAQ ACGFO ACGFS ACIUM ACNCT ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFPUW AFRHN AFTJW AFXIZ AGCQF AGUBO AGWIK AGYEJ AHHHB AIEXJ AIIUN AIKHN AITUG AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU AXJTR BKOJK BLXMC CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q HZ~ IHE J1W K-O KOM L7B M2V M41 MO0 MOBAO N9A O-L O9- OAUVE OP~ OZT P-8 P-9 P2P PC. Q38 ROL RPZ SCC SDF SDG SES SPCBC SSN SSZ T5K Z5R ZGI ~G- .55 .GJ 41~ 53G AACTN AAQXK AAYJJ ADIYS AFCTW AFJKZ AFKWA AGHFR AI. AJOXV AMFUW ASPBG AVWKF AZFZN FEDTE FGOYB G-2 GBLVA HMQ HVGLF MVM PKN R2- RIG SEW SNS VH1 WUQ X7M XPP AADPK AAIAV ABYKQ AJBFU EFLBG AAYXX AGQPQ AGRNS AIGII APXCP BNPGV CITATION SSH IQODW CGR CUY CVF ECM EIF NPM 7X8 7TK |
ID | FETCH-LOGICAL-c637t-f87d9f8c0efb7decacec3dba8cc6c2f678b0e68982e1471973877d026c4f312a3 |
IEDL.DBID | .~1 |
ISSN | 0006-8993 1872-6240 |
IngestDate | Fri Jul 11 01:42:03 EDT 2025 Fri Jul 11 10:29:32 EDT 2025 Mon Jul 21 09:37:37 EDT 2025 Mon Jul 21 06:02:38 EDT 2025 Wed Apr 02 07:25:52 EDT 2025 Tue Jul 01 01:21:26 EDT 2025 Thu Apr 24 23:11:53 EDT 2025 Fri Feb 23 02:22:40 EST 2024 Sun Feb 23 10:19:11 EST 2025 Tue Aug 26 16:31:44 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | P-glycoprotein BCRP Alzheimer's disease MRP4 Blood–brain barrier Human Nervous system diseases Alzheimer disease Blood―brain barrier Central nervous system Glycoprotein Blood brain barrier Cerebral disorder Encephalon Central nervous system disease Degenerative disease ABC transporter |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 CC BY 4.0 Copyright © 2010 Elsevier B.V. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c637t-f87d9f8c0efb7decacec3dba8cc6c2f678b0e68982e1471973877d026c4f312a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
PMID | 20727860 |
PQID | 756660098 |
PQPubID | 23462 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_817608747 proquest_miscellaneous_762272577 proquest_miscellaneous_756660098 pubmed_primary_20727860 pascalfrancis_primary_23327553 crossref_primary_10_1016_j_brainres_2010_08_034 crossref_citationtrail_10_1016_j_brainres_2010_08_034 elsevier_sciencedirect_doi_10_1016_j_brainres_2010_08_034 elsevier_clinicalkeyesjournals_1_s2_0_S0006899310018160 elsevier_clinicalkey_doi_10_1016_j_brainres_2010_08_034 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2010-10-28 |
PublicationDateYYYYMMDD | 2010-10-28 |
PublicationDate_xml | – month: 10 year: 2010 text: 2010-10-28 day: 28 |
PublicationDecade | 2010 |
PublicationPlace | Amsterdam |
PublicationPlace_xml | – name: Amsterdam – name: Netherlands |
PublicationTitle | Brain research |
PublicationTitleAlternate | Brain Res |
PublicationYear | 2010 |
Publisher | Elsevier B.V Elsevier |
Publisher_xml | – name: Elsevier B.V – name: Elsevier |
References | Miller, Tavares, Johanson, Hovanesian, Donahue, Gonzales, Silverberg, Stopa (bb0115) 2008; 1230 Frankfort, Doodeman, Bakker, Tulner, van Campen, Smits, Beijnen (bb0060) 2006; 1 Leschziner, Andrew, Pirmohamed, Johnson (bb0090) 2007; 7 Zlokovic (bb0200) 2008; 57 Caricasole, Copani, Caraci, Aronica, Rozemuller, Caruso, Storto, Gaviraghi, Terstappen, Nicoletti (bb0025) 2004; 24 Hoffmeyer, Burk, von Richter, Arnold, Brockmoller, Johne, Cascorbi, Gerloff, Roots, Eichelbaum, Brinkmann (bb0075) 2000; 97 Braak, Braak (bb0020) 1995; 16 Liebner, Corada, Bangsow, Babbage, Taddei, Czupalla, Reis, Felici, Wolburg, Fruttiger, Taketo, von Melchner, Plate, Gerhardt, Dejana (bb0095) 2008; 183 Lam, Liu, Lu, Shapiro, Renoir, Sharom, Reiner (bb0100) 2001; 76 Chishti, Yang, Janus, Phinney, Horne, Pearson, Strome, Zuker, Loukides, French, Turner, Lozza, Grilli, Kunicki, Morissette, Paquette, Gervais, Bergeron, Fraser, Carlson, George-Hyslop, Westaway (bb0030) 2001; 276 Schinkel (bb0150) 1997; 8 Tai, Loughlin, Male, Romero (bb0165) 2009; 29 Warren, Zerangue, Woodford, Roberts, Tate, Feng, Li, Feuerstein, Gibbs, Smith, de Morias, Dower, Koller (bb0185) 2009; 59 Ek, Wong, Liddelow, Johansson, Dziegielewska, Saunders (bb0055) 2010; 197 Lim, Kania, Wijesuriya, Chawla, Sethi, Pulaski, Romero, Couraud, Weksler, Hladky, Barrand (bb0105) 2008; 106 Bell, Zlokovic (bb0015) 2009; 118 Vogelgesang, Kuhnke, Jedlitschky, Jucker, Mosyagin, Pahnke, Cascorbi, Kroemer, Walker, Warzok (bb0180) 2006; 112 Nies, Jedlitschky, Konig, Herold-Mende, Steiner, Schmitt, Keppler (bb0120) 2004; 129 Kuhnke, Jedlitschky, Grube, Krohn, Jucker, Mosyagin, Cascorbi, Walker, Kroemer, Warzok, Vogelgesang (bb0085) 2007; 17 Roberts, Black, Raman, Woodford, Zhou, Haggerty, Yan, Cwirla, Grindstaff (bb0135) 2008; 155 Desai, Schneider, Li, Carvey, Hendey (bb0045) 2009; 116 Horwood, Davis (bb0080) 1994; 425 Vogelgesang, Cascorbi, Schroeder, Pahnke, Kroemer, Siegmund, Kunert-Keil, Walker, Warzok (bb0175) 2002; 12 Donahue, Flaherty, Johanson, Duncan, Silverberg, Miller, Tavares, Yang, Wu, Sabo, Hovanesian, Stopa (bb0050) 2006; 112 Daneman, Agalliu, Zhou, Kuhnert, Kuo, Barres (bb0040) 2009; 106 Hartz, Miller, Bauer (bb0070) 2010; 77 Fung, Gottesman (bb0065) 2009; 1794 Sadler (bb0145) 1998; 67 Potschka (bb0130) 2010; 125 Miller, Bauer, Hartz (bb0110) 2008; 60 Xiong, Callaghan, Jones, Bai, Rasquinha, Smith, Pei, Walker, Lue, Stanimirovic, Zhang (bb0195) 2009; 29 Cirrito, Deane, Fagan, Spinner, Parsadanian, Finn, Jiang, Prior, Sagare, Bales, Paul, Zlokovic, Piwnica-Worms, Holtzman (bb0035) 2005; 115 Simpson, Ince, Lace, Forster, Shaw, Matthews, Savva, Brayne, Wharton (bb0155) 2010; 31 Albelda, Muller, Buck, Newman (bb0010) 1991; 114 Pahnke, Wolkenhauer, Krohn, Walker (bb0125) 2008; 5 Thal, Griffin, de Vos, Ghebremedhin (bb0170) 2008; 115 Rodriguez, Olabarria, Chvatal, Verkhratsky (bb0140) 2009; 16 Spudich, Kilic, Xing, Kilic, Rentsch, Wunderli-Allenspach, Bassetti, Hermann (bb0160) 2006; 9 Westerlund, Belin, Anvret, Hakansson, Nissbrandt, Lind, Sydow, Olson, Galter (bb0190) 2009; 15 Abbott, Ronnback, Hansson (bb0005) 2006; 7 Warren (10.1016/j.brainres.2010.08.034_bb0185) 2009; 59 Caricasole (10.1016/j.brainres.2010.08.034_bb0025) 2004; 24 Spudich (10.1016/j.brainres.2010.08.034_bb0160) 2006; 9 Horwood (10.1016/j.brainres.2010.08.034_bb0080) 1994; 425 Rodriguez (10.1016/j.brainres.2010.08.034_bb0140) 2009; 16 Miller (10.1016/j.brainres.2010.08.034_bb0110) 2008; 60 Liebner (10.1016/j.brainres.2010.08.034_bb0095) 2008; 183 Bell (10.1016/j.brainres.2010.08.034_bb0015) 2009; 118 Daneman (10.1016/j.brainres.2010.08.034_bb0040) 2009; 106 Cirrito (10.1016/j.brainres.2010.08.034_bb0035) 2005; 115 Pahnke (10.1016/j.brainres.2010.08.034_bb0125) 2008; 5 Schinkel (10.1016/j.brainres.2010.08.034_bb0150) 1997; 8 Nies (10.1016/j.brainres.2010.08.034_bb0120) 2004; 129 Potschka (10.1016/j.brainres.2010.08.034_bb0130) 2010; 125 Donahue (10.1016/j.brainres.2010.08.034_bb0050) 2006; 112 Hoffmeyer (10.1016/j.brainres.2010.08.034_bb0075) 2000; 97 Kuhnke (10.1016/j.brainres.2010.08.034_bb0085) 2007; 17 Miller (10.1016/j.brainres.2010.08.034_bb0115) 2008; 1230 Westerlund (10.1016/j.brainres.2010.08.034_bb0190) 2009; 15 Desai (10.1016/j.brainres.2010.08.034_bb0045) 2009; 116 Fung (10.1016/j.brainres.2010.08.034_bb0065) 2009; 1794 Roberts (10.1016/j.brainres.2010.08.034_bb0135) 2008; 155 Simpson (10.1016/j.brainres.2010.08.034_bb0155) 2010; 31 Xiong (10.1016/j.brainres.2010.08.034_bb0195) 2009; 29 Leschziner (10.1016/j.brainres.2010.08.034_bb0090) 2007; 7 Thal (10.1016/j.brainres.2010.08.034_bb0170) 2008; 115 Hartz (10.1016/j.brainres.2010.08.034_bb0070) 2010; 77 Lam (10.1016/j.brainres.2010.08.034_bb0100) 2001; 76 Chishti (10.1016/j.brainres.2010.08.034_bb0030) 2001; 276 Abbott (10.1016/j.brainres.2010.08.034_bb0005) 2006; 7 Vogelgesang (10.1016/j.brainres.2010.08.034_bb0180) 2006; 112 Albelda (10.1016/j.brainres.2010.08.034_bb0010) 1991; 114 Zlokovic (10.1016/j.brainres.2010.08.034_bb0200) 2008; 57 Lim (10.1016/j.brainres.2010.08.034_bb0105) 2008; 106 Tai (10.1016/j.brainres.2010.08.034_bb0165) 2009; 29 Ek (10.1016/j.brainres.2010.08.034_bb0055) 2010; 197 Braak (10.1016/j.brainres.2010.08.034_bb0020) 1995; 16 Sadler (10.1016/j.brainres.2010.08.034_bb0145) 1998; 67 Frankfort (10.1016/j.brainres.2010.08.034_bb0060) 2006; 1 Vogelgesang (10.1016/j.brainres.2010.08.034_bb0175) 2002; 12 |
References_xml | – volume: 17 start-page: 347 year: 2007 end-page: 353 ident: bb0085 article-title: MDR1-P-Glycoprotein (ABCB1) Mediates Transport of Alzheimer's amyloid-beta peptides—implications for the mechanisms of Abeta clearance at the blood–brain barrier publication-title: Brain Pathol. – volume: 125 start-page: 118 year: 2010 end-page: 127 ident: bb0130 article-title: Targeting regulation of ABC efflux transporters in brain diseases: a novel therapeutic approach publication-title: Pharmacol. Therap. – volume: 57 start-page: 178 year: 2008 end-page: 201 ident: bb0200 article-title: The blood–brain barrier in health and chronic neurodegenerative disorders publication-title: Neuron – volume: 15 start-page: 422 year: 2009 end-page: 424 ident: bb0190 article-title: Association of a polymorphism in the ABCB1 gene with Parkinson's disease publication-title: Parkinsonism Relat. Disord. – volume: 106 start-page: 641 year: 2009 end-page: 646 ident: bb0040 article-title: Wnt/beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis publication-title: Proc. Natl Acad. Sci. USA – volume: 76 start-page: 1121 year: 2001 end-page: 1128 ident: bb0100 article-title: beta-Amyloid efflux mediated by p-glycoprotein publication-title: J. Neurochem. – volume: 59 start-page: 404 year: 2009 end-page: 413 ident: bb0185 article-title: Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including human publication-title: Pharmacol. Res. – volume: 112 start-page: 355 year: 2006 end-page: 367 ident: bb0180 article-title: P-glycoprotein (ABCB1) mediates transport of Alzheimer's beta-amyloid peptides publication-title: Acta Neuropathol. – volume: 1 start-page: 13 year: 2006 ident: bb0060 article-title: ABCB1 genotypes and haplotypes in patients with dementia and age-matched non-demented control patients publication-title: Mol. Neurodegener. – volume: 97 start-page: 3473 year: 2000 end-page: 3478 ident: bb0075 article-title: Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo publication-title: Proc. Natl Acad. Sci. USA – volume: 77 start-page: 715 year: 2010 end-page: 723 ident: bb0070 article-title: Restoring blood–brain barrier P-glycoprotein reduces brain amyloid-β in a mouse model of Alzheimer's disease publication-title: Molec. Pharmacol. – volume: 197 start-page: 51 year: 2010 end-page: 59 ident: bb0055 article-title: Efflux mechanisms at the developing brain barriers: ABC-transporters in the fetal and post-natal rat publication-title: Toxicol. Lett. – volume: 118 start-page: 103 year: 2009 end-page: 113 ident: bb0015 article-title: Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer's disease publication-title: Acta Neuropathol. – volume: 60 start-page: 196 year: 2008 end-page: 209 ident: bb0110 article-title: Modulation of P-glycoprotein at the blood–brain barrier: opportunities to improve central nervous system pharmacotherapy publication-title: Pharmacol. Rev. – volume: 115 start-page: 3285 year: 2005 end-page: 3290 ident: bb0035 article-title: P-glycoprotein deficiency at the blood–brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model publication-title: J. Clin. Invest. – volume: 183 start-page: 409 year: 2008 end-page: 417 ident: bb0095 article-title: Wnt/beta-catenin signaling controls development of the blood–brain barrier publication-title: J. Cell Biol. – volume: 29 start-page: 5463 year: 2009 end-page: 5475 ident: bb0195 article-title: ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood–brain barrier for Aβ publication-title: J. Neurosci. – volume: 5 start-page: 396 year: 2008 end-page: 405 ident: bb0125 article-title: Clinico-pathologic function of cerebral ABC transporters—implications for the pathogenesis of Alzheimer's disease publication-title: Curr. Alzheimer Res. – volume: 16 start-page: 378 year: 2009 end-page: 385 ident: bb0140 article-title: Astroglia in dementia and Alzheimer's disease publication-title: Cell Death Different. – volume: 129 start-page: 349 year: 2004 end-page: 360 ident: bb0120 article-title: Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain publication-title: Neurosci. – volume: 8 start-page: 161 year: 1997 end-page: 170 ident: bb0150 article-title: The physiological function of drug-transporting P-glycoproteins publication-title: Semin. Cancer Biol. – volume: 276 start-page: 21562 year: 2001 end-page: 21570 ident: bb0030 article-title: Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695 publication-title: J. Biol. Chem. – volume: 116 start-page: 587 year: 2009 end-page: 597 ident: bb0045 article-title: Evidence of angiogenic vessels in Alzheimer's disease publication-title: J. Neural Trans. – volume: 9 start-page: 487 year: 2006 end-page: 488 ident: bb0160 article-title: Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia publication-title: Nat. Neurosci. – volume: 112 start-page: 405 year: 2006 end-page: 415 ident: bb0050 article-title: RAGE, LRP-1, and amyloid disease publication-title: Acta Neuropathol. – volume: 7 start-page: 154 year: 2007 end-page: 179 ident: bb0090 article-title: ABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research publication-title: Pharmacogenom. J. – volume: 12 start-page: 535 year: 2002 end-page: 541 ident: bb0175 article-title: Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans publication-title: Pharmacogenetics – volume: 1794 start-page: 860 year: 2009 end-page: 871 ident: bb0065 article-title: A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function publication-title: Biochim. Biophys. Acta – volume: 425 start-page: 69 year: 1994 end-page: 72 ident: bb0080 article-title: Immunolabelling of hippocampal microvessel glucose transporter protein is reduced in Alzheimer's disease publication-title: Virchows Arch. – volume: 67 start-page: 395 year: 1998 end-page: 424 ident: bb0145 article-title: Biochemistry and genetics of von Willebrand factor publication-title: Annu. Rev. Biochem. – volume: 29 start-page: 1079 year: 2009 end-page: 1083 ident: bb0165 article-title: P-glycoprotein and breast cancer resistance protein restrict apical-to-basolateral permeability of human brain endothelium to amyloid-beta publication-title: J. Cereb. Blood Flow Metab. – volume: 24 start-page: 6021 year: 2004 end-page: 6027 ident: bb0025 article-title: Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain publication-title: J. Neurosci. – volume: 114 start-page: 1059 year: 1991 end-page: 1068 ident: bb0010 article-title: Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule publication-title: J. Cell Biol. – volume: 16 start-page: 271 year: 1995 end-page: 284 ident: bb0020 article-title: Staging of Alzheimer's disease-related neurofibrillary changes publication-title: Neurobiol. Aging – volume: 7 start-page: 41 year: 2006 end-page: 53 ident: bb0005 article-title: Astrocyte–endothelial interactions at the blood–brain barrier publication-title: Nat. Rev. Neurosci. – volume: 106 start-page: 1855 year: 2008 end-page: 1865 ident: bb0105 article-title: Activation of beta-catenin signalling by GSK-3 inhibition increases p-glycoprotein expression in brain endothelial cells publication-title: J. Neurochem. – volume: 1230 start-page: 273 year: 2008 end-page: 280 ident: bb0115 article-title: Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease publication-title: Brain Res. – volume: 31 start-page: 578 year: 2010 end-page: 590 ident: bb0155 article-title: Astrocyte phenotypes in relation to Alzheimer-type pathology in the ageing brain publication-title: Neurobiol. Aging – volume: 115 start-page: 599 year: 2008 end-page: 609 ident: bb0170 article-title: Cerebral amyloid angiopathy and its relationship to Alzheimer's disease publication-title: Acta Neuropathol. – volume: 155 start-page: 423 year: 2008 end-page: 438 ident: bb0135 article-title: Subcellular localization of transporters along the rat blood–brain barrier and blood–cerebral–spinal fluid barrier by in vivo biotinylation publication-title: Neurosci. – volume: 12 start-page: 535 year: 2002 ident: 10.1016/j.brainres.2010.08.034_bb0175 article-title: Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans publication-title: Pharmacogenetics doi: 10.1097/00008571-200210000-00005 – volume: 118 start-page: 103 year: 2009 ident: 10.1016/j.brainres.2010.08.034_bb0015 article-title: Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer's disease publication-title: Acta Neuropathol. doi: 10.1007/s00401-009-0522-3 – volume: 57 start-page: 178 year: 2008 ident: 10.1016/j.brainres.2010.08.034_bb0200 article-title: The blood–brain barrier in health and chronic neurodegenerative disorders publication-title: Neuron doi: 10.1016/j.neuron.2008.01.003 – volume: 116 start-page: 587 year: 2009 ident: 10.1016/j.brainres.2010.08.034_bb0045 article-title: Evidence of angiogenic vessels in Alzheimer's disease publication-title: J. Neural Trans. doi: 10.1007/s00702-009-0226-9 – volume: 29 start-page: 1079 year: 2009 ident: 10.1016/j.brainres.2010.08.034_bb0165 article-title: P-glycoprotein and breast cancer resistance protein restrict apical-to-basolateral permeability of human brain endothelium to amyloid-beta publication-title: J. Cereb. Blood Flow Metab. doi: 10.1038/jcbfm.2009.42 – volume: 155 start-page: 423 year: 2008 ident: 10.1016/j.brainres.2010.08.034_bb0135 article-title: Subcellular localization of transporters along the rat blood–brain barrier and blood–cerebral–spinal fluid barrier by in vivo biotinylation publication-title: Neurosci. doi: 10.1016/j.neuroscience.2008.06.015 – volume: 67 start-page: 395 year: 1998 ident: 10.1016/j.brainres.2010.08.034_bb0145 article-title: Biochemistry and genetics of von Willebrand factor publication-title: Annu. Rev. Biochem. doi: 10.1146/annurev.biochem.67.1.395 – volume: 17 start-page: 347 year: 2007 ident: 10.1016/j.brainres.2010.08.034_bb0085 article-title: MDR1-P-Glycoprotein (ABCB1) Mediates Transport of Alzheimer's amyloid-beta peptides—implications for the mechanisms of Abeta clearance at the blood–brain barrier publication-title: Brain Pathol. doi: 10.1111/j.1750-3639.2007.00075.x – volume: 106 start-page: 641 year: 2009 ident: 10.1016/j.brainres.2010.08.034_bb0040 article-title: Wnt/beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0805165106 – volume: 15 start-page: 422 year: 2009 ident: 10.1016/j.brainres.2010.08.034_bb0190 article-title: Association of a polymorphism in the ABCB1 gene with Parkinson's disease publication-title: Parkinsonism Relat. Disord. doi: 10.1016/j.parkreldis.2008.11.010 – volume: 112 start-page: 405 year: 2006 ident: 10.1016/j.brainres.2010.08.034_bb0050 article-title: RAGE, LRP-1, and amyloid disease publication-title: Acta Neuropathol. doi: 10.1007/s00401-006-0115-3 – volume: 1794 start-page: 860 year: 2009 ident: 10.1016/j.brainres.2010.08.034_bb0065 article-title: A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function publication-title: Biochim. Biophys. Acta doi: 10.1016/j.bbapap.2009.02.014 – volume: 129 start-page: 349 year: 2004 ident: 10.1016/j.brainres.2010.08.034_bb0120 article-title: Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain publication-title: Neurosci. doi: 10.1016/j.neuroscience.2004.07.051 – volume: 276 start-page: 21562 year: 2001 ident: 10.1016/j.brainres.2010.08.034_bb0030 article-title: Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M100710200 – volume: 76 start-page: 1121 year: 2001 ident: 10.1016/j.brainres.2010.08.034_bb0100 article-title: beta-Amyloid efflux mediated by p-glycoprotein publication-title: J. Neurochem. doi: 10.1046/j.1471-4159.2001.00113.x – volume: 125 start-page: 118 year: 2010 ident: 10.1016/j.brainres.2010.08.034_bb0130 article-title: Targeting regulation of ABC efflux transporters in brain diseases: a novel therapeutic approach publication-title: Pharmacol. Therap. doi: 10.1016/j.pharmthera.2009.10.004 – volume: 7 start-page: 41 year: 2006 ident: 10.1016/j.brainres.2010.08.034_bb0005 article-title: Astrocyte–endothelial interactions at the blood–brain barrier publication-title: Nat. Rev. Neurosci. doi: 10.1038/nrn1824 – volume: 8 start-page: 161 year: 1997 ident: 10.1016/j.brainres.2010.08.034_bb0150 article-title: The physiological function of drug-transporting P-glycoproteins publication-title: Semin. Cancer Biol. doi: 10.1006/scbi.1997.0068 – volume: 115 start-page: 599 year: 2008 ident: 10.1016/j.brainres.2010.08.034_bb0170 article-title: Cerebral amyloid angiopathy and its relationship to Alzheimer's disease publication-title: Acta Neuropathol. doi: 10.1007/s00401-008-0366-2 – volume: 106 start-page: 1855 year: 2008 ident: 10.1016/j.brainres.2010.08.034_bb0105 article-title: Activation of beta-catenin signalling by GSK-3 inhibition increases p-glycoprotein expression in brain endothelial cells publication-title: J. Neurochem. doi: 10.1111/j.1471-4159.2008.05537.x – volume: 29 start-page: 5463 year: 2009 ident: 10.1016/j.brainres.2010.08.034_bb0195 article-title: ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood–brain barrier for Aβ1–40 peptides publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.5103-08.2009 – volume: 16 start-page: 271 year: 1995 ident: 10.1016/j.brainres.2010.08.034_bb0020 article-title: Staging of Alzheimer's disease-related neurofibrillary changes publication-title: Neurobiol. Aging doi: 10.1016/0197-4580(95)00021-6 – volume: 7 start-page: 154 year: 2007 ident: 10.1016/j.brainres.2010.08.034_bb0090 article-title: ABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research publication-title: Pharmacogenom. J. doi: 10.1038/sj.tpj.6500413 – volume: 197 start-page: 51 issue: 1 year: 2010 ident: 10.1016/j.brainres.2010.08.034_bb0055 article-title: Efflux mechanisms at the developing brain barriers: ABC-transporters in the fetal and post-natal rat publication-title: Toxicol. Lett. doi: 10.1016/j.toxlet.2010.04.025 – volume: 112 start-page: 355 year: 2006 ident: 10.1016/j.brainres.2010.08.034_bb0180 article-title: P-glycoprotein (ABCB1) mediates transport of Alzheimer's beta-amyloid peptides publication-title: Acta Neuropathol. – volume: 31 start-page: 578 year: 2010 ident: 10.1016/j.brainres.2010.08.034_bb0155 article-title: Astrocyte phenotypes in relation to Alzheimer-type pathology in the ageing brain publication-title: Neurobiol. Aging doi: 10.1016/j.neurobiolaging.2008.05.015 – volume: 183 start-page: 409 year: 2008 ident: 10.1016/j.brainres.2010.08.034_bb0095 article-title: Wnt/beta-catenin signaling controls development of the blood–brain barrier publication-title: J. Cell Biol. doi: 10.1083/jcb.200806024 – volume: 1 start-page: 13 year: 2006 ident: 10.1016/j.brainres.2010.08.034_bb0060 article-title: ABCB1 genotypes and haplotypes in patients with dementia and age-matched non-demented control patients publication-title: Mol. Neurodegener. doi: 10.1186/1750-1326-1-13 – volume: 97 start-page: 3473 year: 2000 ident: 10.1016/j.brainres.2010.08.034_bb0075 article-title: Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.97.7.3473 – volume: 1230 start-page: 273 year: 2008 ident: 10.1016/j.brainres.2010.08.034_bb0115 article-title: Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease publication-title: Brain Res. doi: 10.1016/j.brainres.2008.06.124 – volume: 59 start-page: 404 year: 2009 ident: 10.1016/j.brainres.2010.08.034_bb0185 article-title: Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including human publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2009.02.007 – volume: 24 start-page: 6021 year: 2004 ident: 10.1016/j.brainres.2010.08.034_bb0025 article-title: Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.1381-04.2004 – volume: 16 start-page: 378 year: 2009 ident: 10.1016/j.brainres.2010.08.034_bb0140 article-title: Astroglia in dementia and Alzheimer's disease publication-title: Cell Death Different. doi: 10.1038/cdd.2008.172 – volume: 9 start-page: 487 year: 2006 ident: 10.1016/j.brainres.2010.08.034_bb0160 article-title: Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia publication-title: Nat. Neurosci. doi: 10.1038/nn1676 – volume: 5 start-page: 396 year: 2008 ident: 10.1016/j.brainres.2010.08.034_bb0125 article-title: Clinico-pathologic function of cerebral ABC transporters—implications for the pathogenesis of Alzheimer's disease publication-title: Curr. Alzheimer Res. doi: 10.2174/156720508785132262 – volume: 114 start-page: 1059 year: 1991 ident: 10.1016/j.brainres.2010.08.034_bb0010 article-title: Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule publication-title: J. Cell Biol. doi: 10.1083/jcb.114.5.1059 – volume: 77 start-page: 715 year: 2010 ident: 10.1016/j.brainres.2010.08.034_bb0070 article-title: Restoring blood–brain barrier P-glycoprotein reduces brain amyloid-β in a mouse model of Alzheimer's disease publication-title: Molec. Pharmacol. doi: 10.1124/mol.109.061754 – volume: 115 start-page: 3285 year: 2005 ident: 10.1016/j.brainres.2010.08.034_bb0035 article-title: P-glycoprotein deficiency at the blood–brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model publication-title: J. Clin. Invest. doi: 10.1172/JCI25247 – volume: 425 start-page: 69 year: 1994 ident: 10.1016/j.brainres.2010.08.034_bb0080 article-title: Immunolabelling of hippocampal microvessel glucose transporter protein is reduced in Alzheimer's disease publication-title: Virchows Arch. doi: 10.1007/BF00193951 – volume: 60 start-page: 196 year: 2008 ident: 10.1016/j.brainres.2010.08.034_bb0110 article-title: Modulation of P-glycoprotein at the blood–brain barrier: opportunities to improve central nervous system pharmacotherapy publication-title: Pharmacol. Rev. doi: 10.1124/pr.107.07109 |
SSID | ssj0003390 |
Score | 2.360444 |
Snippet | Multidrug efflux transporters of the ATP-Binding cassette (ABC) family, P-glycoprotein (Pgp), multidrug-resistance associated protein 4 (MRP4) and breast... Abstract Multidrug efflux transporters of the ATP-Binding cassette (ABC) family, P-glycoprotein (Pgp), multidrug-resistance associated protein 4 (MRP4) and... |
SourceID | proquest pubmed pascalfrancis crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 228 |
SubjectTerms | Adult and adolescent clinical studies Aged Aged, 80 and over Alzheimer Disease - pathology Alzheimer's disease Amyloid - metabolism ATP Binding Cassette Transporter, Sub-Family G, Member 2 ATP-Binding Cassette Transporters - genetics ATP-Binding Cassette Transporters - metabolism ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism BCRP Biological and medical sciences Blood–brain barrier Brain - pathology Case-Control Studies Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Endothelial Cells - metabolism Glial Fibrillary Acidic Protein - metabolism Humans Intercellular Signaling Peptides and Proteins - metabolism Male Medical sciences Microvessels - metabolism Middle Aged MRP4 Multidrug Resistance-Associated Proteins - metabolism Neoplasm Proteins - metabolism Neurology Organic mental disorders. Neuropsychology P-glycoprotein Plaque, Amyloid - pathology Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry von Willebrand Factor - genetics von Willebrand Factor - metabolism |
Title | ABC efflux transporters in brain vasculature of Alzheimer's subjects |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0006899310018160 https://www.clinicalkey.es/playcontent/1-s2.0-S0006899310018160 https://dx.doi.org/10.1016/j.brainres.2010.08.034 https://www.ncbi.nlm.nih.gov/pubmed/20727860 https://www.proquest.com/docview/756660098 https://www.proquest.com/docview/762272577 https://www.proquest.com/docview/817608747 |
Volume | 1358 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR1di9QwMBzniyCinh_1Y8mD6FN30yRt0se6eqxfh4gH9xaaNME99rrLZhfUB3-7kzbd85BVUSgUSqZNpvOdmQxCT53g8FtNnnIO3MRLLVINZmxqjRSSBRO6a8ny_qSYnfI3Z_nZAZoOtTAhrTLK_l6md9I6PplEbE5W83mo8SUFeAshQg1qqgh-O-ciUPn4-2WaB2N9nCV4zmH0T1XC52Md2jCAWxtTvOSYML5PQd1Y1R7Q5vp-F_sN0k4xHd9CN6NFiat-0rfRgW3voKOqBW_64it-hrsczy54foReVi-m2Dq32H7Bm92x5muP5y3uZoljZmrYV8BLh6vFt892fmHXzz32Wx2CNv4uOj1-9Wk6S2MfhdQUTGxSJ0VTOmmIdVo01tTGGtboWhpTGOpAXWliAZWS2gx0VSmYFKIB58xwxzJas3vosF229gHCpOFcg8WY54LynDRlVoPqy7Sh0jTw2gTlA_KUiYeMh14XCzVkk52rAekqIF2FJpiMJ2iyg1v1x2z8EUIM_0YNRaQg9hRogn-DtD5yr1eZ8lQR9QuFJajcQV4h0r_66ugKAe2WSRmjIs9ZgvBAUQpYPOzb1K1dbr0SYHIX4eDX3wwpKBUgfcX-ITITBZHgPSbofk-vl1MgYMXKgjz8j_U9Qte7xAq4qHyMDjfrrX0C9tpGjzqGHKFr1fTjuw_h_vrt7OQH8-tA3A |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR1Nb9Mw1JrGASSEgPERPoYPCE5pHduxnWMpTAW2nTZpNyt2bK1Tl1ZNK7Ed-O08J07HhAoIpJwiv8R-fp_2-0DorZccttXmKefATbwwMjVgxqbOKqlYMKHblixHx2Jyyr-c5Wc7aNznwoSwyij7O5neSuv4ZhixOVxMpyHHlwjwFsIJNagpAX77HQ7sG9oYDL7fxHkw1h20BNc5DP8pTfhiYEIfBvBrY4yXGhDGt2mo-4uyAbz5ruHFdou01UwHD9GDaFLiUTfrR2jH1Y_R3qgGd_ryCr_DbZBne3q-hz6OPoyx8362_oZXm7rmywZPa9zOEsfQ1HCxgOcej2bX52566ZbvG9ysTTi1aZ6g04NPJ-NJGhsppFYwuUq9klXhlSXOG1k5W1pnWWVKZa2w1IO-MsQBLhV1GSirQjIlZQXemeWeZbRkT9FuPa_dc4RJxbkBkzHPJeU5qYqsBN2XGUuVreCzCcp75Gkbq4yHZhcz3YeTXege6TogXYcumIwnaLiBW3R1Nv4IIfu90X0WKcg9Darg3yBdE9m30ZluqCb6FxJLULGBvEWlf_XX_VsEtFkmZYzKPGcJwj1FaeDxcHFT1m6-brQEm1uEyq-_GSIolSB-5fYhKpOCKHAfE_Sso9ebKRAwY5UgL_5jfW_Q3cnJ0aE-_Hz89SW610ZZwEPVK7S7Wq7dazDeVma_Zc4f39JA1Q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=ABC+efflux+transporters+in+brain+vasculature+of+Alzheimer%27s+subjects&rft.jtitle=Brain+research&rft.au=Wijesuriya%2C+Hasini+C.&rft.au=Bullock%2C+Jocelyn+Y.&rft.au=Faull%2C+Richard+L.M.&rft.au=Hladky%2C+Stephen+B.&rft.date=2010-10-28&rft.pub=Elsevier+B.V&rft.issn=0006-8993&rft.eissn=1872-6240&rft.volume=1358&rft.spage=228&rft.epage=238&rft_id=info:doi/10.1016%2Fj.brainres.2010.08.034&rft.externalDocID=S0006899310018160 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00068993%2FS0006899310X00476%2Fcov150h.gif |